Funded PhD Scholarship in Gene: Explore the biology of gene therapy vector production in cells to optimize manufacturing processes. This funded PhD scholarship, offered by the Hull School of Natural Sciences in collaboration with Hull York Medical School and the York Biomedical Research Institute, addresses the inefficiencies in gene therapy manufacturing, aiming to make these life-changing therapies more globally accessible.
Funded PhD Scholarship in Gene Therapy Vector Production
Summary Table:
| Funding | Funded PhD |
|---|---|
| Duration | 3 years (full time) 6 years (part time) |
| Application Deadline | 15 February 2024 |
| Start Date | September 2024 |
Study Area:
The PhD project encompasses bioinformatics, molecular & cell biology, virology, biochemistry, and high-end microscopy. The focus is on spatial proteomics combined with AI-informed construct design to enhance the understanding of gene therapy vector production.
Scholarship Description:
The project addresses the inefficiencies in manufacturing gene therapies, aiming to reduce costs and increase global availability. It involves multidisciplinary research, combining various scientific approaches to shed light on the biology of gene therapy vector production. The selected candidate will collaborate with experienced supervisors and become part of a vibrant research community.
Eligibility:
Applicants should have a minimum 2:1 degree in Molecular or Cell Biology. A taught MSc or Masters by Research in a relevant subject is advantageous. The scholarship is available for both full-time and part-time study.
Required Documents:
- Personal Statement
- Motivation for PhD study
- Interest in the project
- Skill set matching project requirements
- Additional training needs
- Significance of research in the area
- Potential future research directions
How to Apply:
Complete the SurveyMonkey application, providing the required documents. The closing date for applications is 15 February 2024.
Last Date for Apply:
15 February 2024
Note: Selected candidates will be notified in April 2024, and the scholarship commences in September 2024.
For more information, contact Dr. André Voelzmann at andre.voelzmann@hull.ac.uk.
Summary Table:
| Funding | Funded PhD |
|---|---|
| Duration | 3 years (full time) 6 years (part time) |
| Application Deadline | 15 February 2024 |
| Start Date | September 2024 |
Study Area:
The PhD project encompasses bioinformatics, molecular & cell biology, virology, biochemistry, and high-end microscopy. The focus is on spatial proteomics combined with AI-informed construct design to enhance the understanding of gene therapy vector production.
Scholarship Description:
The project addresses the inefficiencies in manufacturing gene therapies, aiming to reduce costs and increase global availability. It involves multidisciplinary research, combining various scientific approaches to shed light on the biology of gene therapy vector production.
Eligibility:
Applicants should have a minimum 2:1 degree in Molecular or Cell Biology. A taught MSc or Masters by Research in a relevant subject is advantageous. The scholarship is available for both full-time and part-time study.
Required Documents:
- Personal Statement
- Motivation for PhD study
- Interest in the project
- Skill set matching project requirements
- Additional training needs
- Significance of research in the area
- Potential future research directions
How to Apply:
Complete the SurveyMonkey application, providing the required documents. The closing date for applications is 15 February 2024.
Last Date for Apply:
15 February 2024
Note: Selected candidates will be notified in April 2024, and the scholarship commences in September 2024.
For more information, contact Dr. André Voelzmann at andre.voelzmann@hull.ac.uk.
